Nicardipine Pregnancy and Breastfeeding Warnings
Brand names: Cardene, Cardene IV, Cardene SR
Medically reviewed by Drugs.com. Last updated on Jun 20, 2025.
Nicardipine Pregnancy Warnings
This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus.
-According to some authorities: Use is contraindicated.
US FDA pregnancy category:
-IV infusion: C
-Oral capsules: Not assigned
Risk summary: Inadequate data available on the use of this drug in pregnant women to inform a drug-related risk. An embryocidal effect was observed in animal studies.
Animal studies have revealed evidence of embryolethality and fetal harm. In humans, transient fetal heart rate decelerations and neonatal hypotension and acidosis (pH less than 7.25) have been reported. There are no controlled data in human pregnancy.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.
Nicardipine Breastfeeding Warnings
Use should be avoided; however, this drug has been used without apparent harmful effects. Use is contraindicated per some authorities.
Excreted into human milk: Yes (in small amounts)
In two studies involving a total of 18 infants exposed to this drug through breast milk during the postpartum period, the calculated daily infant dose was less than 0.3 mcg and there were no adverse events observed.
See also
References for pregnancy information
- (2002) "Product Information. Cardene (nicardipine)." Syntex Laboratories Inc
- (2025) "Product Information. NiCARdipine Hydrochloride (niCARdipine)." ANI Pharmaceuticals, Inc.
- (2022) "Product Information. Cardene IV (niCARdipine)." Baxter Healthcare Corporation
References for breastfeeding information
- (2002) "Product Information. Cardene (nicardipine)." Syntex Laboratories Inc
- United States National Library of Medicine (2013) Toxnet. Toxicology Data Network. http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.